Since eating disorders (EDs) are significant yet underestimated and are rising in number as a mental health issue worldwide [9], which increases mortality risk and contributes to reduced quality of life [10], the question that must inevitably arise is about the correlation between the popularity of GLP-1 ARs and the prevalence of EDs. This evidence concerns the gene GLP1R and Ehlers-Danlos syndrome.